We've invested over 2 million dollars in preeclampsia research
February 2023 - The 2023 Vision Grant application phase is now open.
The Preeclampsia Foundation's affiliate organization Preeclampsia Foundation Canada will award two medical research Vision Grants to study preeclampsia, HELLP syndrome, and related hypertensive disorders of pregnancy, up to $25,000 CAD.
Vision Grants are intended to provide initial funding for novel, innovative research by promising young investigators that will advance progress towards detection, prevention, or treatment of preeclampsia, HELLP syndrome, and other hypertensive disorders of pregnancy. Post-doctoral, Clinical Fellows, or Early Stage Investigators only are eligible to apply. Projects with potential to alter clinical management and improve patient outcomes will receive priority, but any well-considered research proposal will be accepted for review. International applications are welcome; however, submissions must be in English. The Foundation has committed to funding grants that address known research knowledge gaps.
The application deadline is Wednesday, April 12, 2023, with award notification in August 2023.
Questions? Contact VisionGrants@preeclampsia.org
PREVIOUS VISION GRANT RECIPIENTS
August 2022 - The 2023 Peter Joseph Pappas Research Grant application cycle is now closed.
Named for the infant son of preeclampsia survivor Lauren Pappas and her husband Clement, the program seeks to award multiple grants totaling up to $200,000 each year. The ultimate goal of this grant program is to drive research that will eliminate the delivery of pre-term babies as an intervention for severe preeclampsia, HELLP syndrome, and related hypertensive disorders of pregnancy. Letters of Intent that are of interest to the scientific review committee and the Preeclampsia Foundation’s Board of Directors will then be invited to submit full applications by October 8, 2022 with award decisions rendered in December 2022.
Read more about the Peter Joseph Pappas Research Grant Program.
Questions? Contact PJPGrants@preeclampsia.org
PREVIOUS PETER JOSEPH PAPPAS GRANT RECIPIENTS
Please note: The EMPOWER program is not currently being funded. No applications are being accepted at this time.
EMPOWER (EMpowering Progress in Obstetric and Women's hEalth Research) was established to create partnerships between mentors and single sites or groups within low- and middle-income countries to improve clinical and health services research into the hypertensive disorders of pregnancy.
When available, funding is for a two-year research project. The immediate objective is the completion of a project designed by a local investigator and, when appropriate, the dissemination of the results of the study to change practices and improve care.
EMPOWER is a collaboration of the International Society for the Study of Hypertension in Pregnancy, the Preeclampsia Foundation, PRE-EMPT/Global Pregnancy Collaboration, and supporting organization New Zealand Action on Pre-eclampsia.
PREVIOUS EMPOWER GRANT RECIPIENTS
Questions? Contact empower@preeclampsia.org
Please contact our Research Manager if you would like the Preeclampsia Foundation to help you recruit participants for a research study or focus group, or have any questions about the Preeclampsia Registry.
Frequently asked questions about the Preeclampsia Registry, a patient-driven registry and biobank.
The Preeclampsia Foundation offers research funding, study recruitment, and other patient engagement services to researchers.
Is there a connection between maternal diet and preeclampsia? The PRECISE Network research team and I recently completed an evidence review to compile information on maternal nutritional factors that...
What you’ll learn in this article: Many risk factors contribute to an individual’s chance of getting preeclampsia. These risk factors may be genetic, physical, environmental, and even s...
San Francisco, Calif. – February 8, 2023 – The Preeclampsia Foundation announced today the recipient of its 2023 Peter Joseph Pappas Research Grants at the Society for Maternal Fetal Medic...
San Francisco, CA – February 8, 2023 – Preeclampsia Foundation Canada announced today at the Society for Maternal-Fetal Medicine’s (SMFM) 43rd Annual Meeting – The Pregnancy Me...
First Trimester Preterm Preeclampsia Prediction with Metabolite Biomarkers: Differential Prediction According to Maternal Body Mass Index Recent research suggests that there may be different types of...